Core Insights - Dova Health Intelligence Inc. collaborates with Mayo Clinic to develop and validate DovaVision UC Mayo Endoscopic Score (MES), an AI tool for scoring ulcerative colitis disease activity from colonoscopy videos [1][3] Company Overview - Dova Health Intelligence specializes in AI-driven solutions for gastrointestinal disease assessment, focusing on improving diagnosis, monitoring, and treatment decision-making [6] - The company's flagship technologies include DovaVision UC MES for ulcerative colitis assessment, DovaVision BE for Barrett's esophagus, and DovaSound for intestinal ultrasound image capture [6] Collaboration Details - The partnership aims to refine DovaVision UC MES for integration into gastroenterology workflows and prepare for FDA regulatory clearance [3][4] - Mayo Clinic's expertise in inflammatory bowel disease (IBD) care and research will enhance the validation process of DovaVision UC MES [4][5] Technology Impact - DovaVision UC MES utilizes computer vision and deep learning to standardize scoring and reduce variability in mucosal healing assessments, which is crucial for IBD management [2] - The collaboration is expected to set new standards in digital assessment and accelerate innovation in clinical trial design and patient care [5]